Insulin Receptor Substrate-1 (IRS-1) and IRS-2 expression levels are associated with prognosis in non-small cell lung cancer (NSCLC)

Piper, AJ; Clark, JL; Mercado-Matos, J; Matthew-Onabanjo, AN; Hsieh, CC; Akalin, A; Shaw, LM

Shaw, LM (reprint author), Univ Massachusetts, Med Sch, Dept Mol Cell & Canc Biol, Worcester, MA 01605 USA.

PLOS ONE, 2019; 14 (8):

Abstract

The insulin-like growth factor-1 (IGF-1) signaling pathway has been implicated in non-small cell lung cancer (NSCLC) outcomes and resistance to target......

Full Text Link